Скачать с ютуб New Antipsychotic Drug Cobenfy: The Miracle Cure for Schizophrenia? в хорошем качестве

New Antipsychotic Drug Cobenfy: The Miracle Cure for Schizophrenia?

The FDA has just (September 26, 2024) approved the first new antipsychotic drug in decades for the treatment of schizophrenia in adults. Unlike older drugs, which target dopamine receptors, Cobenfy (xanomeline and trospium chloride) works on cholinergic receptors, providing a new option for people who haven't found relief or who had harsh side effects from other treatments. Cobenfy will be available in oral capsules in a twice a day (BID) dosing formulation. Will this new medication, with its unique mechanism of action, be effective enough to herald in the next generation of antipsychotics? Timestamps 0:00 Introduction 1:20 FDA article 5:50 Personal thoughts on Cobenfy FDA article: https://www.fda.gov/news-events/press... NPR article: https://www.npr.org/sections/shots-he... --- Balance l Justice l Mizan Hi, I'm Dr. Nahim Mizan, MD, medicolegal consulting physician with Family Medicine training, Los Angeles native, and founder of Mizan Coaching, LLC. I wholeheartedly took the leap of faith from clinical medicine to medicolegal consulting, earning certifications in medical ethics and jurisprudence. I focus on accomplishing 3 goals: to improve healthcare systems globally, to educate my fellow physicians to improve and protect their clinical practices, and to advocate for patients in a system riddled with inequity. Follow our channel and we'll unravel the niche field of the medicolegal sector and learn how best to operate within the system to maximize patient advocacy and prevent medical malpractice. --- Medicolegal 101 playlist:    • Medicolegal 101   --- Support our channel: https://buymeacoffee.com/drmizan If you are interested in 1-on-1 coaching (medical life coaching, alternative medical careers, entry into the medicolegal sector) or for business inquiries, contact us at [email protected] 📨 #Cobenfy #Schizophrenia #Antipsychotics #drmizan #medicolegal #medicalnews